Richard A. Paulson, President and CEO at Karyopharm Therapeutics Inc. (KPTI), sold 245 shares at $3.74 ($916) on 2025-04-04, disclosed to the SEC on 2025-04-07.
Open-market sale of $916 KPTI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2025-09-16 | $8K | — | Filing → |
| KPTI | SELL | 2025-05-07 | $2K | — | Filing → |
| KPTI | SELL | 2025-03-06 | $147K | — | Filing → |